- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03704311
Evaluation of Mitochondrial Function in Myofascial Trigger Points Cohort Pilot Study Using High-resolution Respirometry (MitoTrigger)
October 11, 2018 updated by: Medical University Innsbruck
Evaluation of Mitochondrial Function in Chronic Myofascial Trigger Points - A Prospective Cohort Pilot Study Using High-resolution Respirometry
This pilot study established a minimally invasive biopsy technique to obtain high-quality MTrP tissue samples to evaluate mitochondrial function via high-resolution respirometry.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Myofascial trigger points (MTrPs) are hyperirritable areas in the fascia of the affected muscle, possibly related to mitochondrial impairment.
They can result in pain and hypoxic areas within the muscle.
This pilot study established a minimally invasive biopsy technique to obtain high-quality MTrP tissue samples to evaluate mitochondrial function via high-resolution respirometry.
Secondary objectives included the safety of the biopsy procedure assessed via clinical wound healing (number of patients with signs for local infection and inflammation).
For this purpose, twenty healthy males participated in this study, 10 with a diagnosis of myofascial pain in the musculus (m.) trapezius MTrP (TTP group) and 10 with a diagnosis of myofascial pain in the m.
gluteus medius (GTP group).
The affected muscle was biopsied followed by a biopsy from the vastus lateralis to be used as a control.
Measurements of oxygen consumption were carried out using high-resolution respirometry.
Study Type
Interventional
Enrollment (Actual)
20
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 45 years (ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- Male patients aged 18-45 years
- Clinical diagnosis of myofascial pain syndrome within the region of the shoulder-neck muscles or the lumbogluteal region and the presence of an MTrP, defined as a firm palpation of a hard, tender nodule resulting in a spontaneous pain complaint
- with symptoms present for 1 to 12 months
Exclusion Criteria:
- Signs that the participant's prescriptive compliance was not expected (e.g., lack of cooperation)
- Disorders of the respiratory tract
- Neurological disorders, in particular neurodegenerative and neuromuscular diseases
- Disorders of the cardiovascular system or the musculoskeletal system
- Civil servants and military service personnel.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: BASIC_SCIENCE
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Single
Evaluation of mitochondrial function after muscle biopsy and follow-up for surgical complications.
|
Local anesthesia was applied to the superficial skin covering the MTrP of each participant.
Percutaneous biopsy sampling optimized with a suction-enhancement technique was used to obtain muscle biopsies of the m.
trapezius MTrP or the m.
gluteus medius MTrP from each participant using small Bergstrom muscle biopsy needle, 8 swg (4.0mm) x 100 mm (Dixons Surgical Instruments, Essex, United Kingdom).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Mitochondrial function in myofascial trigger points
Time Frame: Baseline measurement
|
Mitochondrial respiration was assessed from muscle biopsy samples obtained from trigger points of the musculus trapezius and the musculus gluteus medius
|
Baseline measurement
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of participants with biopsy-related impaired wound healing
Time Frame: Baseline and follow-up assessment (1 week after the baseline biopsy)
|
Clinical wound assessment (number of patients with signs for local infection and inflammation)
|
Baseline and follow-up assessment (1 week after the baseline biopsy)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Michael J Fischer, MD, PhD, Medical University Innsbruck
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
October 1, 2013
Primary Completion (ACTUAL)
February 1, 2014
Study Completion (ACTUAL)
December 1, 2014
Study Registration Dates
First Submitted
October 9, 2018
First Submitted That Met QC Criteria
October 11, 2018
First Posted (ACTUAL)
October 12, 2018
Study Record Updates
Last Update Posted (ACTUAL)
October 12, 2018
Last Update Submitted That Met QC Criteria
October 11, 2018
Last Verified
October 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- MUInnsbruck
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Myofascial Pain
-
Bozyaka Training and Research HospitalEnrolling by invitationMyofascial Pain | Trigger Point Pain, Myofascial | Myofascial Trigger Point PainTurkey
-
Washington University School of MedicineRecruitingMyofascial Pain | Pelvic Pain | Pelvic Floor Myofascial PainUnited States
-
Universidad Complutense de MadridUnknownNeck Pain | Myofascial Pain | Myofascial Pain Syndrome | Myofascial Trigger Point PainSpain
-
Universidad Complutense de MadridRecruitingTrigger Point Pain, Myofascial | Myofascial Pain Syndrome of Neck | Myofacial PainSpain
-
Beth Israel Deaconess Medical CenterMassachusetts General HospitalRecruitingMyofascial Pain | Trigger Point Pain, MyofascialUnited States
-
University of ArizonaEnrolling by invitationMyofascial Pain | Myofascial Trigger Point PainUnited States
-
Universidad Complutense de MadridCompletedMyofascial Pain | Trigger Point Pain, MyofascialSpain
-
Quiropraxia y EquilibrioUniversidad Nacional Andres BelloCompletedMyofascial Trigger Point Pain (MTrP)Chile
-
University Hospitals Cleveland Medical CenterAllerganCompletedMyofascial Pain Syndromes | Trigger Point Pain, Myofascial | Myofascial Trigger Point PainUnited States
-
Indonesia UniversityCompletedMyofascial Pain of Upper Trapezius MuscleIndonesia
Clinical Trials on Muscle biopsy
-
University Medical Center NijmegenUnknownSepsis | Mechanical VentilationNetherlands
-
Norman MangnerCompletedHeart Failure | Ischemic Myocardiopathy | Dilatative MyocardiopathyGermany
-
University Hospital, LilleUnknown
-
University Hospital, MontpellierHill-RomTerminatedSpinal Cord Injury | Pressure Ulcer | Paraplegia | BedsoreFrance
-
Delafontaine HospitalCompleted
-
Hasselt UniversityJessa HospitalCompletedCritical Illness | Cachexia | Muscle Atrophy | Muscle Loss | Muscle WastingBelgium
-
National Institute on Aging (NIA)Terminated
-
Purdue UniversityCompletedFlaccid Muscle ToneUnited States
-
University Hospital, AngersCompleted